Table 3. Cardiac biomarkers among the study population.

This table shows the values of cardiac troponin I and NT-ProBNP among the study population

Sig.: significance; *: statistically significant; p: p-value for comparing the three studied groups; p₁: p-value for comparing between no dysfunction and mild asymptomatic dysfunction; p₂: p-value for comparing between no dysfunction and moderate asymptomatic dysfunction; p₃: p-value for comparing between mild and moderate asymptomatic dysfunction

Biomarkers	Total sample	No dysfunction	Asymptomatic dysfunction		Test of sig.	p-value
			Mild	Moderate
Troponin
Baseline	0.11 (0.10 – 0.12)	0.11 (0.10 – 0.12)	0.11 (0.10 – 0.12)	0.10 (0.10 – 0.13)	H = 0.552	0.759
3 months	0.11 (0.10 – 0.12)	0.11 (0.10 – 0.12)	0.11 (0.10 – 0.11)	0.10 (0.10 – 0.11)	H =0.668	0.716
6 months	0.11 (0.10 – 0.12)	0.11 (0.10 – 0.11)	0.10 (0.10 – 0.13)	0.10 (0.10 – 0.12)	H =0.192	0.909
NT-ProBNP
Baseline	58.0 (34.0 – 80.0)	52.50 (34.0 – 68.0)	80.10 (62.0 – 105.0)	57.95 (20.0 – 128.5)	H =5.467	0.065
3 months	51.30 (30.75 – 87.25)	50.20 (30.10 – 83.0)	99.50 (44.0 – 154.0)	39.0 (26.25 – 87.0)	H =6.613*	0.037*
Significance between the groups		p1=0.015*, p2=0.643,p3=0.530
6 months	53.0 (30.05 – 83.0)	45 (28.0 – 77.80)	72 (54.50 – 115.0)	52 (23.15 – 58.50)	H= 5.045	0.080